Amita Moirangthem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amita Moirangthem has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Shubha Rajendra Phadke
Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
15 shared publications Arya Shambhavi
Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
8 shared publicationsSuzena Masih
Sanjay Gandhi Post‐Graduate Institute Lucknow Uttar Pradesh India
5 shared publicationsDeepti Saxena
Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
4 shared publications- Deepti Saxena
Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
4 shared publications Kausik Mandal
Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
4 shared publications
Latest Publications
- 5 November 2026
- Published by Wiley in Clinical Genetics
Expanding the Clinical and Molecular Spectrum of Progressive Familial Intrahepatic Cholestasis Associated With Biallelic Variants in LSR
Progressive familial intrahepatic cholestasis (PFIC) comprises autosomal recessive disorders causing early‐onset cholestasis that may progress to cirrhosis and liver failure. Although more than 13 genes are associated with PFIC, some patients remain genetically undiagnosed. LSR , encoding lipolysis‐stimulated lipoprotein receptor, has recently emerged as a candidate gene. LSR contributes to tricellular tight‐junction integrity and epithelial barrier function. We report four additional patients from three unrelated families with biallelic LSR variants, expanding the reported clinical and molecular spectrum. Features included intractable pruritus, cholestasis with normal or mildly elevated gamma‐glutamyl transferase (GGT), progressive hepatic dysfunction and variable extrahepatic findings, including growth failure, neurodevelopmental delay, seizures and microcephaly. Two patients died from end‐stage liver disease. Review of published cases suggests a predominantly progressive cholestatic phenotype with variable syndromic features. These findings support consideration of LSR variants in unresolved PFIC and the value of comprehensive genomic testing.
- 5 November 2026
- Published by Wiley in Clinical Genetics
Expanding the Clinical and Molecular Spectrum of Progressive Familial Intrahepatic Cholestasis Associated With Biallelic Variants in LSR
Progressive familial intrahepatic cholestasis (PFIC) comprises autosomal recessive disorders causing early‐onset cholestasis that may progress to cirrhosis and liver failure. Although more than 13 genes are associated with PFIC, some patients remain genetically undiagnosed. LSR , encoding lipolysis‐stimulated lipoprotein receptor, has recently emerged as a candidate gene. LSR contributes to tricellular tight‐junction integrity and epithelial barrier function. We report four additional patients from three unrelated families with biallelic LSR variants, expanding the reported clinical and molecular spectrum. Features included intractable pruritus, cholestasis with normal or mildly elevated gamma‐glutamyl transferase (GGT), progressive hepatic dysfunction and variable extrahepatic findings, including growth failure, neurodevelopmental delay, seizures and microcephaly. Two patients died from end‐stage liver disease. Review of published cases suggests a predominantly progressive cholestatic phenotype with variable syndromic features. These findings support consideration of LSR variants in unresolved PFIC and the value of comprehensive genomic testing.
- Open Access
- 30 September 2026
- Published by Wolters Kluwer Health in Genetic Clinics
- Vol. 19 (4) , 2-7
Clinical and Molecular Spectrum of Ataxia Telangiectasia in Thirteen Indian Families: A Case Series
Background: Ataxia-telangiectasia (A-T) is a rare, progressive neurodegenerative disorder caused by biallelic pathogenic variants in ATM, characterised by childhood-onset ataxia, recurrent infections, immunological abnormalities, and oculocutaneous telangiectasia. Objectives: To describe the clinical, laboratory, and molecular spectrum of genetically confirmed A-T in Indian families. Materials and Methods: Thirteen Indian families with genetically confirmed A-T were evaluated. Clinical, laboratory, immunological, and molecular findings were retrospectively reviewed. Exome sequencing was used for molecular diagnosis. Results: We describe thirteen Indian families with genetically confirmed A-T, highlighting their clinical, laboratory, and molecular features. Affected individuals commonly presented with early-onset progressive ataxia, ocular telangiectasia and variable immunoglobulin abnormalities. Exome sequencing identified a total of 18 variants in the ATM gene, including 6 nonsense, 5 frameshift, 4 missense, and 3 splice-site variants. Conclusion: This series highlights the clinical and molecular spectrum of A-T in Indian families and emphasises the importance of early recognition and molecular diagnosis for timely management and genetic counselling.
- 30 September 2026
- Published by Wolters Kluwer Health in Genetic Clinics
- Vol. 19 (4) , 2-7
Open AccessClinical and Molecular Spectrum of Ataxia Telangiectasia in Thirteen Indian Families: A Case Series
Background: Ataxia-telangiectasia (A-T) is a rare, progressive neurodegenerative disorder caused by biallelic pathogenic variants in ATM, characterised by childhood-onset ataxia, recurrent infections, immunological abnormalities, and oculocutaneous telangiectasia. Objectives: To describe the clinical, laboratory, and molecular spectrum of genetically confirmed A-T in Indian families. Materials and Methods: Thirteen Indian families with genetically confirmed A-T were evaluated. Clinical, laboratory, immunological, and molecular findings were retrospectively reviewed. Exome sequencing was used for molecular diagnosis. Results: We describe thirteen Indian families with genetically confirmed A-T, highlighting their clinical, laboratory, and molecular features. Affected individuals commonly presented with early-onset progressive ataxia, ocular telangiectasia and variable immunoglobulin abnormalities. Exome sequencing identified a total of 18 variants in the ATM gene, including 6 nonsense, 5 frameshift, 4 missense, and 3 splice-site variants. Conclusion: This series highlights the clinical and molecular spectrum of A-T in Indian families and emphasises the importance of early recognition and molecular diagnosis for timely management and genetic counselling.
- Open Access
- 12 September 2026
- Published by S. Karger AG in Molecular Syndromology
- p. 1
Phenotypic Evolution in a Boy with MYL11-Related Distal Arthrogryposis Type 1C: A Case Report
Introduction: Distal arthrogryposis (DA) type 1C (DA1C) is characterized by multiple congenital contractures, scoliosis, and short stature. It is caused by biallelic variants in MYL11(MYLPF), which encodes a regulatory myosin light chain in fast-twitch skeletal muscle. Case Presentation: We evaluated a 3-year-old boy from a consanguineous family presenting with features of distal arthrogryposis. Clinical, radiographic, and electrophysiological assessments were performed. He had distal joint contractures, camptodactyly, cutaneous syndactyly of the second and third toes, absent distal interphalangeal creases, left-sided inguinal hernia, facial dysmorphism, and short stature. Exome sequencing failed to detect any candidate variants. On re-analysis after 7 years, we identified a homozygous NC_000016.10:g.30377860G>T; MYL11(NM_013292.5):c.470G>T; p.(Cys157Phe) variant, which causes DA1C. This variant was reported by Chong et al. in 2020 in seven patients with MYL11-related disorders and was classified as pathogenic. Conclusions: This study extends the spectrum of MYL11-related disorders by identifying a phenotype of distal arthrogryposis with marked facial dysmorphism reminiscent of DA2, along with other findings like absent distal interphalangeal joint creases, hirsutism, inguinal hernia, and syndactyly of the 2nd and 3rd toes. This report also highlights the critical role of periodic re-analysis of previously uninformative exome cases.
- 12 September 2026
- Published by S. Karger AG in Molecular Syndromology
- p. 1
Open AccessPhenotypic Evolution in a Boy with MYL11-Related Distal Arthrogryposis Type 1C: A Case Report
Introduction: Distal arthrogryposis (DA) type 1C (DA1C) is characterized by multiple congenital contractures, scoliosis, and short stature. It is caused by biallelic variants in MYL11(MYLPF), which encodes a regulatory myosin light chain in fast-twitch skeletal muscle. Case Presentation: We evaluated a 3-year-old boy from a consanguineous family presenting with features of distal arthrogryposis. Clinical, radiographic, and electrophysiological assessments were performed. He had distal joint contractures, camptodactyly, cutaneous syndactyly of the second and third toes, absent distal interphalangeal creases, left-sided inguinal hernia, facial dysmorphism, and short stature. Exome sequencing failed to detect any candidate variants. On re-analysis after 7 years, we identified a homozygous NC_000016.10:g.30377860G>T; MYL11(NM_013292.5):c.470G>T; p.(Cys157Phe) variant, which causes DA1C. This variant was reported by Chong et al. in 2020 in seven patients with MYL11-related disorders and was classified as pathogenic. Conclusions: This study extends the spectrum of MYL11-related disorders by identifying a phenotype of distal arthrogryposis with marked facial dysmorphism reminiscent of DA2, along with other findings like absent distal interphalangeal joint creases, hirsutism, inguinal hernia, and syndactyly of the 2nd and 3rd toes. This report also highlights the critical role of periodic re-analysis of previously uninformative exome cases.
- Open Access
- 2 September 2026
- Published by Wiley in American Journal of Medical Genetics Part A
Exome Sequencing Uncovers Phenotypic and Genotypic Heterogeneity in 196 Indian Families Evaluated for Autoinflammatory Disorders
Autoinflammatory disorders (AIDs) are a clinically heterogeneous group of inborn errors of immunity primarily caused by dysregulation in the innate immune system. Clinical diagnosis is often challenging due to clinical heterogeneity and the overlapping phenotypes with other inborn errors of immunity and monogenic conditions that mimic AIDs. Worldwide, and especially in India, there is a lack of systematic large cohort studies employing genomic testing early in the course of evaluation for individuals with autoinflammatory disease. Herein, we describe our experience using exome sequencing as a first‐tier investigation in evaluating 202 individuals from 196 unrelated families with possible monogenic AIDs. Consanguinity was noted in 19% of the families. Recurrent fever was the most common manifestation (90%), frequently associated with arthritis (54%), skin lesions (38%), hepatosplenomegaly (23%), oral ulcers (21%) and lymphadenopathy (21%). Exome sequencing could identify a molecular diagnosis in 50 of 196 (25%) families of whom 30 (60%) had variants in genes associated with monogenic AIDs, 10 (20%) had other distinct inborn errors of immunity and 10 (20%) had monogenic conditions with phenotypic overlap with AIDs. We identified 21 variants in genes associated with monogenic AIDs, of which 20 (95%) were single nucleotide variants and one (5%) was a copy number variant. Notably, seven (33%) of the 21 variants were novel. This study highlights the diagnostic challenges posed by phenotypic overlap in this group of disorders and demonstrates the utility of exome sequencing in enabling a timely diagnosis, including conditions that mimic AIDs thereby facilitating targeted therapy and genetic counseling.
- 2 September 2026
- Published by Wiley in American Journal of Medical Genetics Part A
Open AccessExome Sequencing Uncovers Phenotypic and Genotypic Heterogeneity in 196 Indian Families Evaluated for Autoinflammatory Disorders
Autoinflammatory disorders (AIDs) are a clinically heterogeneous group of inborn errors of immunity primarily caused by dysregulation in the innate immune system. Clinical diagnosis is often challenging due to clinical heterogeneity and the overlapping phenotypes with other inborn errors of immunity and monogenic conditions that mimic AIDs. Worldwide, and especially in India, there is a lack of systematic large cohort studies employing genomic testing early in the course of evaluation for individuals with autoinflammatory disease. Herein, we describe our experience using exome sequencing as a first‐tier investigation in evaluating 202 individuals from 196 unrelated families with possible monogenic AIDs. Consanguinity was noted in 19% of the families. Recurrent fever was the most common manifestation (90%), frequently associated with arthritis (54%), skin lesions (38%), hepatosplenomegaly (23%), oral ulcers (21%) and lymphadenopathy (21%). Exome sequencing could identify a molecular diagnosis in 50 of 196 (25%) families of whom 30 (60%) had variants in genes associated with monogenic AIDs, 10 (20%) had other distinct inborn errors of immunity and 10 (20%) had monogenic conditions with phenotypic overlap with AIDs. We identified 21 variants in genes associated with monogenic AIDs, of which 20 (95%) were single nucleotide variants and one (5%) was a copy number variant. Notably, seven (33%) of the 21 variants were novel. This study highlights the diagnostic challenges posed by phenotypic overlap in this group of disorders and demonstrates the utility of exome sequencing in enabling a timely diagnosis, including conditions that mimic AIDs thereby facilitating targeted therapy and genetic counseling.
- Open Access
- 15 August 2026
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 69 (8) , 646-654
Prognosis of pediatric hepatic Wilson disease with ATP7B loss of function variants
Background: Genotype-phenotype correlations in Wilson disease (WD) have so far been inconclusive.Purpose: ATP7B variants with loss of function (LOF) may have a different trajectory. Since genotypes in Asia differ from the West, we aimed to correlate LOF variants of ATP7B with the severity and outcome of hepatic WD.Methods: Patients with a confirmed diagnosis of WD (Leipzig criteria ≥4) were prospectively enrolled. Genetic sequencing of ATP7Bmutations was assessed by Whole-exome sequencing. For patients with variants of uncertain significance, Sanger sequencing was additionally performed on their parents to identify the inherited variants. In silico analyses were used to predict the pathogenicity of variants. Mutations that resulted in at least one truncation (nonsense, frameshift, splice site, deletions) and nontruncation (missense, synonymous) protein were defined as LOF and no LOF (NLF) respectively. Phenotypes, biochemical parameters, and outcomes were analyzed.Results: One hundred sixteen hepatic WD children (84 boys, median age at diagnosis 8.9±3.3 years) with biallelic ATP7B mutations (62 different variants) were enrolled. The most common LOF (n=79) and NLF (n=37) variants were c.813C>A and c.3809A>G. Advanced liver disease (76% vs. 4%, P=0.004), portal hypertension (44% vs. 24%, P=0.03), neurological (39% vs. 16%, P=0.01) and renal involvement (44% vs. 13%, P=0.01) were significantly higher in LOF than in NLF. c.813C>A had higher serum exchangeable copper (6.8±4.4 μmol/L vs. 1.4±3.5 μmol/L, P=0.04) and lower disappearance of the Kayser-Fleischer ring (4% vs. 49%, P= 0.01) than c.3809A>G variants. Over a follow-up of 6.1±4.7 years, a single LOF variant did not show a poorer liver or overall outcomes in comparison to ≥2 LOF variants.Conclusion: A single ATP7B LOF variant, especially c.813C>A was associated with advanced liver disease, portal hypertension, and extrahepatic involvement. LOF variants did not affect liver or overall outcomes.
- 15 August 2026
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 69 (8) , 646-654
Open AccessPrognosis of pediatric hepatic Wilson disease with ATP7B loss of function variants
Background: Genotype-phenotype correlations in Wilson disease (WD) have so far been inconclusive.Purpose: ATP7B variants with loss of function (LOF) may have a different trajectory. Since genotypes in Asia differ from the West, we aimed to correlate LOF variants of ATP7B with the severity and outcome of hepatic WD.Methods: Patients with a confirmed diagnosis of WD (Leipzig criteria ≥4) were prospectively enrolled. Genetic sequencing of ATP7Bmutations was assessed by Whole-exome sequencing. For patients with variants of uncertain significance, Sanger sequencing was additionally performed on their parents to identify the inherited variants. In silico analyses were used to predict the pathogenicity of variants. Mutations that resulted in at least one truncation (nonsense, frameshift, splice site, deletions) and nontruncation (missense, synonymous) protein were defined as LOF and no LOF (NLF) respectively. Phenotypes, biochemical parameters, and outcomes were analyzed.Results: One hundred sixteen hepatic WD children (84 boys, median age at diagnosis 8.9±3.3 years) with biallelic ATP7B mutations (62 different variants) were enrolled. The most common LOF (n=79) and NLF (n=37) variants were c.813C>A and c.3809A>G. Advanced liver disease (76% vs. 4%, P=0.004), portal hypertension (44% vs. 24%, P=0.03), neurological (39% vs. 16%, P=0.01) and renal involvement (44% vs. 13%, P=0.01) were significantly higher in LOF than in NLF. c.813C>A had higher serum exchangeable copper (6.8±4.4 μmol/L vs. 1.4±3.5 μmol/L, P=0.04) and lower disappearance of the Kayser-Fleischer ring (4% vs. 49%, P= 0.01) than c.3809A>G variants. Over a follow-up of 6.1±4.7 years, a single LOF variant did not show a poorer liver or overall outcomes in comparison to ≥2 LOF variants.Conclusion: A single ATP7B LOF variant, especially c.813C>A was associated with advanced liver disease, portal hypertension, and extrahepatic involvement. LOF variants did not affect liver or overall outcomes.
- Open Access
- 13 July 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (S1) , 147
Correction to: Position Statement of the Indian Academy of Medical Genetics on Next Generation Sequencing-Based Testing for Rare Genetic Disorders
- 13 July 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (S1) , 147
Open AccessCorrection to: Position Statement of the Indian Academy of Medical Genetics on Next Generation Sequencing-Based Testing for Rare Genetic Disorders
- Open Access
- 16 June 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (S1) , 1-7
Position Statement of the Indian Academy of Medical Genetics on Next Generation Sequencing-Based Testing for Rare Genetic Disorders
Next-generation sequencing (NGS)-based tests are being increasingly employed by clinicians for obtaining a genetic diagnosis in individuals and families with possible genetic disorders. However, there is a significant disparity in the genomic knowledge and skills of the clinicians employing these tests for care and management of families with rare genetic disorders. Through the current document, the Society for Indian Academy of Medical Genetics (SIAMG) aims to provide guidance and consideration in terms of the type of tests available, their appropriate applications, and result interpretation in order to make judicious use of these tests for rare disease diagnosis.
- 16 June 2026
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 93 (S1) , 1-7
Open AccessPosition Statement of the Indian Academy of Medical Genetics on Next Generation Sequencing-Based Testing for Rare Genetic Disorders
Next-generation sequencing (NGS)-based tests are being increasingly employed by clinicians for obtaining a genetic diagnosis in individuals and families with possible genetic disorders. However, there is a significant disparity in the genomic knowledge and skills of the clinicians employing these tests for care and management of families with rare genetic disorders. Through the current document, the Society for Indian Academy of Medical Genetics (SIAMG) aims to provide guidance and consideration in terms of the type of tests available, their appropriate applications, and result interpretation in order to make judicious use of these tests for rare disease diagnosis.
- 12 February 2026
- Published by Springer Nature in Journal of Human Genetics
- Vol. 71 (8) , 1-5
Childhood-onset ataxia with dystonia: expanding the spectrum of VWA3B-related disorders
Hereditary cerebellar ataxias are a group of rare genetic disorders that affect coordination, balance, and speech. Childhood-onset forms can be especially severe and difficult to diagnose. The VWA3B gene, though not fully understood, plays a role in brain development and has been linked to autosomal recessive spinocerebellar ataxia type 22 (SCAR22), an adult-onset cerebellar ataxia with variable features. A single family with 3 affected adults has been described to date. We report a 1 year 9 months old boy with early-onset neuroregression and ataxia. Prominent dystonia involving the limbs and eyelids (blepharospasm) was also a novel feature observed in him. Exome sequencing revealed compound heterozygous variants in VWA3B. Unlike the previous report describing a missense variant, our patient had nonsense and frameshift variants. This case highlights the expanding clinical and genotypic spectrum of VWA3B-related ataxia.
- 12 February 2026
- Published by Springer Nature in Journal of Human Genetics
- Vol. 71 (8) , 1-5
Childhood-onset ataxia with dystonia: expanding the spectrum of VWA3B-related disorders
Hereditary cerebellar ataxias are a group of rare genetic disorders that affect coordination, balance, and speech. Childhood-onset forms can be especially severe and difficult to diagnose. The VWA3B gene, though not fully understood, plays a role in brain development and has been linked to autosomal recessive spinocerebellar ataxia type 22 (SCAR22), an adult-onset cerebellar ataxia with variable features. A single family with 3 affected adults has been described to date. We report a 1 year 9 months old boy with early-onset neuroregression and ataxia. Prominent dystonia involving the limbs and eyelids (blepharospasm) was also a novel feature observed in him. Exome sequencing revealed compound heterozygous variants in VWA3B. Unlike the previous report describing a missense variant, our patient had nonsense and frameshift variants. This case highlights the expanding clinical and genotypic spectrum of VWA3B-related ataxia.
- 5 February 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (2) , e268705
Bleeding from umbilicus in a neonate: exploring aetiologies of a common presentation
Bleeding from the umbilical stump is a common clinical presentation with varying aetiologies. A mild amount of bleeding often occurs at the time of cord separation. It is often benign; however, sometimes it may be due to an underlying congenital coagulation disorder, especially when in large amounts. Afibrinogenaemia is an uncommon bleeding disorder characterised by the complete absence or severe deficiency of fibrinogen, a vital protein crucial for the regulation of blood clotting. Its estimated prevalence is around 1 in 1 million newborns and is inherited in an autosomal recessive manner. We report a neonate who was diagnosed with congenital afibrinogenaemia and presented with significant bleeding from the umbilicus. The baby is well managed with fibrinogen replacement therapy. Timely identification and intervention proved pivotal in averting potentially life-threatening bleeding incidents in this neonate.
- 5 February 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (2) , e268705
Bleeding from umbilicus in a neonate: exploring aetiologies of a common presentation
Bleeding from the umbilical stump is a common clinical presentation with varying aetiologies. A mild amount of bleeding often occurs at the time of cord separation. It is often benign; however, sometimes it may be due to an underlying congenital coagulation disorder, especially when in large amounts. Afibrinogenaemia is an uncommon bleeding disorder characterised by the complete absence or severe deficiency of fibrinogen, a vital protein crucial for the regulation of blood clotting. Its estimated prevalence is around 1 in 1 million newborns and is inherited in an autosomal recessive manner. We report a neonate who was diagnosed with congenital afibrinogenaemia and presented with significant bleeding from the umbilicus. The baby is well managed with fibrinogen replacement therapy. Timely identification and intervention proved pivotal in averting potentially life-threatening bleeding incidents in this neonate.